Search results

Skip to results

Type

Status

Last updated

Showing 1 to 3 of 3 results for collagenase clostridium histolyticum

  1. Collagenase clostridium histolyticum for treating Dupuytren's contracture (TA459)

    We have withdrawn the guidance because collagenase clostridium histolyticum (Xiapex) is no longer available in the UK.

    Technology appraisal guidance
    Published
    26 July 2017

  2. Radiation therapy for early Dupuytren's disease (IPG573)

    Evidence-based recommendations on radiation therapy for early Dupuytren’s contractures in adults. This involves directing low energy X-rays at the affected tissue.

    Interventional procedures guidance
    Published
    21 December 2016
    View recommendations

    Sections for IPG573

  3. Past appeals and decisions

    (review) 2 June 2003 TA459 Dupuytren's contracture - collagenase clostridium histolyticum 30 November 2015 TA007 Dyspepsia - proton pump...